The original success of Viagra undeniably transformed the pharmaceutical landscape, but investing in companies strongly reliant on unbranded versions presents a complex picture. While early profits were substantial, the expiration of patents and the appearance of less expensive alternatives have weakened market share. Consequently, a thorough asses